Price target
39.460.000.00%
The 6 analysts offering 1 year price forecasts for HQ1 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to HQ1 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
HQ1 EPS for the last quarter is −1.31 EUR despite the estimation of −0.36 EUR. In the next quarter EPS is expected to reach −0.66 EUR. Track more of ORUKA THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter ORUKA THERAPEUTICS INC revenue is expected to reach 0.00 EUR. Check out ORUKA THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, HQ1 price target is 39.46 EUR with a max estimate of 44.79 EUR and a min estimate of 36.56 EUR. Check if this forecast comes true in a year, meanwhile watch ORUKA THERAPEUTICS INC stock price chart and keep track of the current situation with HQ1 news and stock market news.
We've gathered opinions of 7 analysts rating HQ1 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.